PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE
06/07/2025
PRESCRIBERS 5TH EDITION
Complete test bank_
Pharmacotherapeutics for Advanced Practice Nurse Prescribers
5th Edition
(Woo Robinson) complete all chapters 1-55 latest 2025 A+ graded
T T
E E
S S
T T
B B
A A
N N
K K
June 7, 2025
,PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE
06/07/2025
PRESCRIBERS 5TH EDITION
Table of Contents
Chapter 1. The Role of the Nurse Practitioner ............................................................................................................................................................................................................3
Chapter 2. Review of Basic Principles of Pharmacology .................................................................................................................................................................................................5
Chapter 3. Rational Drug Selection ...............................................................................................................................................................................................................................13
Chapter 4. Legal and Professional Issues in Prescribing ................................................................................................................................................................................................16
Chapter 5. Adverse Drug Reactions ...............................................................................................................................................................................................................................19
Chapter 6. Pharmacoeconomics.....................................................................................................................................................................................................................................25
Chapter 7. Nutrition and Nutraceuticals .........................................................................................................................................................................................................................28
Chapter 8. Herbal Therapy and Nutritional Supplements ...............................................................................................................................................................................................36
Chapter 9. Informatics ...................................................................................................................................................................................................................................................40
Chapter 10. Pharmacoeconomics ...................................................................................................................................................................................................................................45
Chapter 11. Drugs Affecting the Autonomic Nervous System .......................................................................................................................................................................................48
Chapter 12. Drugs Affecting the Central Nervous System .............................................................................................................................................................................................61
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems.............................................................................................................................................................................71
Chapter 14. Drugs Affecting the Respiratory System ....................................................................................................................................................................................................81
Chapter 15. Drugs Affecting the Hematological System ...............................................................................................................................................................................................87
Chapter 16. Drugs Affecting the Immune System ..........................................................................................................................................................................................................92
Chapter 17. Drugs Affecting the Gastrointestinal System ..............................................................................................................................................................................................96
Chapter 18. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs .............................................................................................................................99
Chapter 19. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs.....................................................................................................................................106
Chapter 20. Drugs Affecting the Reproductive System ................................................................................................................................................................................................120
Chapter 22. Drugs Affecting the Integumentary System .............................................................................................................................................................................................134
Chapter 23. Drugs Used in Treating Bacterial Diseases ...............................................................................................................................................................................................140
Chapter 24. Drugs Used to Treat Viral, Fungal, and Protozoal Infections...................................................................................................................................................................146
Chapter 25. Drugs Used in Treating Inflammatory Processes ] ....................................................................................................................................................................................153
Chapter 26. Drugs Used in Treating Eye and Ear Disorders.........................................................................................................................................................................................158
Chapter 27. Alcohol and Drug Addiction ....................................................................................................................................................................................................................162
Chapter 28. Anemia ....................................................................................................................................................................................................................................................167
Chapter 29. Angina......................................................................................................................................................................................................................................................172
Chapter 29. Angina Answer Section ............................................................................................................................................................................................................................178
Chapter 30. Anxiety and Depression ...........................................................................................................................................................................................................................178
Chapter 32. Asthma and Chronic Obstructive Pulmonary Disease ..............................................................................................................................................................................188
Chapter 33. Contraception ...........................................................................................................................................................................................................................................192
Chapter 34. Dermatologic Conditions..........................................................................................................................................................................................................................196
Chapter 35. Diabetes Management ..............................................................................................................................................................................................................................201
Chapter 36. Gastroesophageal Reflux and Peptic Ulcer Disease ..................................................................................................................................................................................212
Chapter 37. Headaches ................................................................................................................................................................................................................................................216
Chapter 38. Heart Failure .............................................................................................................................................................................................................................................220
Chapter 39. Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Syndrome ...........................................................................................................................224
Chapter 39. Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Syndrome......................................................................................................................227
Chapter 40. Hormone Replacement Therapy ...............................................................................................................................................................................................................227
Chapter 40. Hormone Replacement Therapy Answer Section ................................................................................................................................................................................231
June 7, 2025
,PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE
06/07/2025
PRESCRIBERS 5TH EDITION
Chapter 41. Hyperlipidemia.........................................................................................................................................................................................................................................231
Chapter 42. Hypertension Multiple Choice ............................................................................................................................................................................................................236
Chapter 43. Hyperthyroidism and Hypothyroidism ......................................................................................................................................................................................................242
Chapter 44. Pain Management: Acute and Chronic Pain .............................................................................................................................................................................................247
Chapter 45. Pneumonia................................................................................................................................................................................................................................................252
Chapter 46. Smoking Cessation ...................................................................................................................................................................................................................................256
Chapter 47. Sexually Transmitted Infections and Vaginitis .........................................................................................................................................................................................260
Chapter 48. Tuberculosis Multiple Choice .............................................................................................................................................................................................................265
Chapter 49. Upper Respiratory Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ..............................................................................................................................269
Chapter 50. Urinary Tract Infections ............................................................................................................................................................................................................................273
Chapter 51: Women as Patients ....................................................................................................................................................................................................................................277
Chapter 52. Men as Patients.........................................................................................................................................................................................................................................282
Chapter 53. Pediatric Patients ......................................................................................................................................................................................................................................286
Chapter 54. Transgendered Clients as Patients ............................................................................................................................................................................................................290
Chapter 55. Geriatric Patients ......................................................................................................................................................................................................................................296
Chapter 1. The Role of the Nurse Practitioner
Multiple Choice
Identify the choice that best completes the statement or answers the question.
1. Nurse practitioner prescriptive authority is regulated by:
1. The National Council of State Boards of Nursing
2. The U.S. Drug Enforcement Administration
3. The State Board of Nursing for each state
4. The State Board of Pharmacy
2. The benefits to the patient of having an Advanced Practice Registered Nurse (APRN) prescriber
include:
1. Nurses know more about Pharmacology than other prescribers because they take it
both in their basic nursing program and in their APRN program.
2. Nurses care for the patient from a holistic approach and include the patient in
decision making regarding their care.
3. APRNs are less likely to prescribe narcotics and other controlled substances.
4. APRNs are able to prescribe independently in all states, whereas a physician’s
assistant needs to have a physician supervising their practice.
3. Clinical judgment in prescribing includes:
1. Factoring in the cost to the patient of the medication prescribed
2. Always prescribing the newest medication available for the disease process
3. Handing out drug samples to poor patients
4. Prescribing all generic medications to cut costs
June 7, 2025
, PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE
06/07/2025
PRESCRIBERS 5TH EDITION
4. Criteria for choosing an effective drug for a disorder include:
1. Asking the patient what drug they think would work best for them
2. Consulting nationally recognized guidelines for disease management
3. Prescribing medications that are available as samples before writing a prescription
4. Following U.S. Drug Enforcement Administration guidelines for prescribing
5. Nurse practitioner practice may thrive under health-care reform because of:
1. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
2. The fact that nurse practitioners will be able to practice independently
3. The fact that nurse practitioners will have full reimbursement under health-care
reform
4. The ability to shift accountability for Medicaid to the state level
June 7, 2025
06/07/2025
PRESCRIBERS 5TH EDITION
Complete test bank_
Pharmacotherapeutics for Advanced Practice Nurse Prescribers
5th Edition
(Woo Robinson) complete all chapters 1-55 latest 2025 A+ graded
T T
E E
S S
T T
B B
A A
N N
K K
June 7, 2025
,PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE
06/07/2025
PRESCRIBERS 5TH EDITION
Table of Contents
Chapter 1. The Role of the Nurse Practitioner ............................................................................................................................................................................................................3
Chapter 2. Review of Basic Principles of Pharmacology .................................................................................................................................................................................................5
Chapter 3. Rational Drug Selection ...............................................................................................................................................................................................................................13
Chapter 4. Legal and Professional Issues in Prescribing ................................................................................................................................................................................................16
Chapter 5. Adverse Drug Reactions ...............................................................................................................................................................................................................................19
Chapter 6. Pharmacoeconomics.....................................................................................................................................................................................................................................25
Chapter 7. Nutrition and Nutraceuticals .........................................................................................................................................................................................................................28
Chapter 8. Herbal Therapy and Nutritional Supplements ...............................................................................................................................................................................................36
Chapter 9. Informatics ...................................................................................................................................................................................................................................................40
Chapter 10. Pharmacoeconomics ...................................................................................................................................................................................................................................45
Chapter 11. Drugs Affecting the Autonomic Nervous System .......................................................................................................................................................................................48
Chapter 12. Drugs Affecting the Central Nervous System .............................................................................................................................................................................................61
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems.............................................................................................................................................................................71
Chapter 14. Drugs Affecting the Respiratory System ....................................................................................................................................................................................................81
Chapter 15. Drugs Affecting the Hematological System ...............................................................................................................................................................................................87
Chapter 16. Drugs Affecting the Immune System ..........................................................................................................................................................................................................92
Chapter 17. Drugs Affecting the Gastrointestinal System ..............................................................................................................................................................................................96
Chapter 18. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs .............................................................................................................................99
Chapter 19. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs.....................................................................................................................................106
Chapter 20. Drugs Affecting the Reproductive System ................................................................................................................................................................................................120
Chapter 22. Drugs Affecting the Integumentary System .............................................................................................................................................................................................134
Chapter 23. Drugs Used in Treating Bacterial Diseases ...............................................................................................................................................................................................140
Chapter 24. Drugs Used to Treat Viral, Fungal, and Protozoal Infections...................................................................................................................................................................146
Chapter 25. Drugs Used in Treating Inflammatory Processes ] ....................................................................................................................................................................................153
Chapter 26. Drugs Used in Treating Eye and Ear Disorders.........................................................................................................................................................................................158
Chapter 27. Alcohol and Drug Addiction ....................................................................................................................................................................................................................162
Chapter 28. Anemia ....................................................................................................................................................................................................................................................167
Chapter 29. Angina......................................................................................................................................................................................................................................................172
Chapter 29. Angina Answer Section ............................................................................................................................................................................................................................178
Chapter 30. Anxiety and Depression ...........................................................................................................................................................................................................................178
Chapter 32. Asthma and Chronic Obstructive Pulmonary Disease ..............................................................................................................................................................................188
Chapter 33. Contraception ...........................................................................................................................................................................................................................................192
Chapter 34. Dermatologic Conditions..........................................................................................................................................................................................................................196
Chapter 35. Diabetes Management ..............................................................................................................................................................................................................................201
Chapter 36. Gastroesophageal Reflux and Peptic Ulcer Disease ..................................................................................................................................................................................212
Chapter 37. Headaches ................................................................................................................................................................................................................................................216
Chapter 38. Heart Failure .............................................................................................................................................................................................................................................220
Chapter 39. Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Syndrome ...........................................................................................................................224
Chapter 39. Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Syndrome......................................................................................................................227
Chapter 40. Hormone Replacement Therapy ...............................................................................................................................................................................................................227
Chapter 40. Hormone Replacement Therapy Answer Section ................................................................................................................................................................................231
June 7, 2025
,PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE
06/07/2025
PRESCRIBERS 5TH EDITION
Chapter 41. Hyperlipidemia.........................................................................................................................................................................................................................................231
Chapter 42. Hypertension Multiple Choice ............................................................................................................................................................................................................236
Chapter 43. Hyperthyroidism and Hypothyroidism ......................................................................................................................................................................................................242
Chapter 44. Pain Management: Acute and Chronic Pain .............................................................................................................................................................................................247
Chapter 45. Pneumonia................................................................................................................................................................................................................................................252
Chapter 46. Smoking Cessation ...................................................................................................................................................................................................................................256
Chapter 47. Sexually Transmitted Infections and Vaginitis .........................................................................................................................................................................................260
Chapter 48. Tuberculosis Multiple Choice .............................................................................................................................................................................................................265
Chapter 49. Upper Respiratory Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ..............................................................................................................................269
Chapter 50. Urinary Tract Infections ............................................................................................................................................................................................................................273
Chapter 51: Women as Patients ....................................................................................................................................................................................................................................277
Chapter 52. Men as Patients.........................................................................................................................................................................................................................................282
Chapter 53. Pediatric Patients ......................................................................................................................................................................................................................................286
Chapter 54. Transgendered Clients as Patients ............................................................................................................................................................................................................290
Chapter 55. Geriatric Patients ......................................................................................................................................................................................................................................296
Chapter 1. The Role of the Nurse Practitioner
Multiple Choice
Identify the choice that best completes the statement or answers the question.
1. Nurse practitioner prescriptive authority is regulated by:
1. The National Council of State Boards of Nursing
2. The U.S. Drug Enforcement Administration
3. The State Board of Nursing for each state
4. The State Board of Pharmacy
2. The benefits to the patient of having an Advanced Practice Registered Nurse (APRN) prescriber
include:
1. Nurses know more about Pharmacology than other prescribers because they take it
both in their basic nursing program and in their APRN program.
2. Nurses care for the patient from a holistic approach and include the patient in
decision making regarding their care.
3. APRNs are less likely to prescribe narcotics and other controlled substances.
4. APRNs are able to prescribe independently in all states, whereas a physician’s
assistant needs to have a physician supervising their practice.
3. Clinical judgment in prescribing includes:
1. Factoring in the cost to the patient of the medication prescribed
2. Always prescribing the newest medication available for the disease process
3. Handing out drug samples to poor patients
4. Prescribing all generic medications to cut costs
June 7, 2025
, PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE
06/07/2025
PRESCRIBERS 5TH EDITION
4. Criteria for choosing an effective drug for a disorder include:
1. Asking the patient what drug they think would work best for them
2. Consulting nationally recognized guidelines for disease management
3. Prescribing medications that are available as samples before writing a prescription
4. Following U.S. Drug Enforcement Administration guidelines for prescribing
5. Nurse practitioner practice may thrive under health-care reform because of:
1. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
2. The fact that nurse practitioners will be able to practice independently
3. The fact that nurse practitioners will have full reimbursement under health-care
reform
4. The ability to shift accountability for Medicaid to the state level
June 7, 2025
